Literature DB >> 28774816

Redox regulation of the tumor suppressor PTEN by the thioredoxin system and cumene hydroperoxide.

Seong-Jeong Han1, Ying Zhang2, Inyoung Kim2, Kee-Oh Chay2, Hyun Joong Yoon2, Dong Il Jang3, Sung Yeul Yang2, Jiyoung Park4, Hyun Ae Woo4, Iha Park5, Seung-Rock Lee6.   

Abstract

Intracellular redox status influences the oxidation and enzyme activity of the tumor suppressor phosphatase and tensin homolog on chromosome 10 (PTEN). Cumene hydroperoxide (CuHP), an organic hydroperoxide, is a known tumor promoter. However, molecular targets and action mechanism of CuHP in tumor promotion have not been well characterized. In this study, we investigated the effect of CuHP on the redox state of PTEN in HeLa cells. In addition, the intracellular reducing system of oxidized PTEN was analyzed using a biochemical approach and the effect of CuHP on this reducing system was also analyzed. While PTEN oxidized by hydrogen peroxide is progressively converted to its reduced form, PTEN was irreversibly oxidized by exposure to CuHP in HeLa cells. A combination of protein fractionation and mass analysis showed that the reducing system of PTEN was comprised of NADPH, thioredoxin reductase (TrxR), and thioredoxin (Trx). Although CuHP-mediated PTEN oxidation was not reversible in cells, CuHP-oxidized PTEN was reactivated by the exogenous Trx system, indicating that the cellular Trx redox system for PTEN is inactivated by CuHP. We present evidence that PTEN oxidation and the concomitant inhibition of thioredoxin by CuHP results in irreversible oxidation of PTEN in HeLa cells. In addition, ablation of peroxiredoxin (Prdx) enhanced CuHP-induced PTEN oxidation in cells. These results provide a new line of evidence that PTEN might be a crucial determinant of cell fate in response to cellular oxidative stress induced by organic hydroperoxides.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cumene hydroperoxide; PTEN; Reactive oxygen species; Redox signaling; Thioredoxin

Mesh:

Substances:

Year:  2017        PMID: 28774816     DOI: 10.1016/j.freeradbiomed.2017.07.029

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

Review 1.  Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions.

Authors:  Tian Liu; Yiwei Wang; Yubing Wang; Andrew M Chan
Journal:  Cancers (Basel)       Date:  2019-08-26       Impact factor: 6.639

2.  Peroxiredoxin III Protects Tumor Suppressor PTEN from Oxidation by 15-Hydroperoxy-eicosatetraenoic Acid.

Authors:  Ying Zhang; Jiyoung Park; Seong-Jeong Han; Yongwoon Lim; Iha Park; Jong-Suk Kim; Hyun Ae Woo; Seung-Rock Lee
Journal:  Oxid Med Cell Longev       Date:  2019-09-15       Impact factor: 6.543

Review 3.  Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review.

Authors:  Ying Zhang; Yeon Jin Roh; Seong-Jeong Han; Iha Park; Hae Min Lee; Yong Sik Ok; Byung Cheon Lee; Seung-Rock Lee
Journal:  Antioxidants (Basel)       Date:  2020-05-05

4.  The adipocyte-enriched secretory protein tetranectin exacerbates type 2 diabetes by inhibiting insulin secretion from β cells.

Authors:  Fen Liu; Zixin Cai; Yan Yang; George Plasko; Piao Zhao; Xiangyue Wu; Cheng Tang; Dandan Li; Ting Li; Shanbiao Hu; Lei Song; Shaojie Yu; Ran Xu; Hairong Luo; Libin Fan; Ersong Wang; Zhen Xiao; Yujiao Ji; Rong Zeng; Rongxia Li; Juli Bai; Zhiguang Zhou; Feng Liu; Jingjing Zhang
Journal:  Sci Adv       Date:  2022-09-21       Impact factor: 14.957

Review 5.  Redox regulation of tumor suppressor PTEN in cell signaling.

Authors:  Ying Zhang; Jiyoung Park; Seong-Jeong Han; Sung Yeul Yang; Hyun Joong Yoon; Iha Park; Hyun Ae Woo; Seung-Rock Lee
Journal:  Redox Biol       Date:  2020-05-03       Impact factor: 11.799

6.  Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway.

Authors:  Wenjing Zhou; Jiwei Wang; Qichao Qi; Zichao Feng; Bin Huang; Anjing Chen; Di Zhang; Wenjie Li; Qing Zhang; Rolf Bjerkvig; Xingang Li; Jian Wang
Journal:  Cancer Med       Date:  2018-08-05       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.